Table 2.
Table describing the location and treatment of TB patients.
| Variable | All (n = 189) | TB untreated (n = 49) | TB under treatment (n = 140) |
|---|---|---|---|
| TB type | |||
| Pulmonary TB | 149 (78.8%) | 37 (75.5%) | 112 (80.0%) |
| Extrapulmonary TB | 26 (13.8%) | 10 (20.4%) | 16 (11.4%) |
| Disseminated TB | 14 (7.4%) | 2 (4.1%) | 12 (8.6%) |
| TB treatment | |||
| Drug-susceptible TB | 186 (98.4%) | 47 (95.9) | 139 (99.3%) |
| RR-TB | 1 (0.5%) | 0 (0.0%) | 1 (0.7%) |
| Hr-TB | 1 (0.5%) | 1 (2.0%) | 0 (0.0%) |
| XDR-TB | 1 (0.5%) | 1 (2.0%) | 0 (0.0%) |
Variable expressed as a number of subjects (n) and percentage (%).
TB: tuberculosis; RR-TB: rifampicin-resistant TB; Hr-TB: isoniazid-resistant TB; XDR-TB: extensively drug-resistant TB.